We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GeneGo Expands License with Johnson & Johnson
News

GeneGo Expands License with Johnson & Johnson

GeneGo Expands License with Johnson & Johnson
News

GeneGo Expands License with Johnson & Johnson

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GeneGo Expands License with Johnson & Johnson"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GeneGo, Inc. has announced that Johnson & Johnson Pharmaceutical Research & Development, (J&JPRD), a division of Janssen Pharmaceutica N.V., has extended their MetaCore™ license to now include MetaBase™, a database J&JPRD will primarily use for biomarker discovery.

"We are pleased to have this relationship extended," said Julie Bryant, Vice President of Business Development at GeneGo. "We look forward to enhancing our collaboration with the MetaBase integration."

Advertisement